Physician profile
Nina Mohammed
NPI 1194751016
$1,579.97
in general payments reported to CMS, 2019-2025
20 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $92.96 · 2021: $40.22 · 2022: $205 · 2023: $203 · 2024: $132 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.60 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $445.75 | 2019-2022 | |
| Abbvie INC. | $165.14 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.92 | 2020-2025 | |
| Mayne Pharma Commercial LLC | $98.26 | 2022-2025 | |
| Lupin INC. | $97.39 | 2019-2020 | |
| Hologic Sales and Service, LLC | $89.42 | 2025 | Novasure, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $74.73 | 2024-2025 | Slynd |
| Astellas Pharma US INC | $72.07 | 2023-2024 | Veozah |
| Millicent US INC | $64.00 | 2025 | Femlyv |
| Allergan, INC. | $58.01 | 2019-2020 | |
| Therapeuticsmd, INC. | $56.45 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $46.99 | 2019 | |
| Alydia Health | $40.22 | 2021 | |
| Ethicon US, LLC | $37.26 | 2023 | Enseal |
| Smith+Nephew, INC. | $35.60 | 2024 | Pico 7 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $30.11 | 2019-2023 | |
| Agile Therapeutics, INC. | $16.06 | 2023 | Twirla |
| Duchesnay USA Incorporated | $14.69 | 2019 | |
| Meditrina | $11.90 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Mohammed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.